Literature DB >> 10392609

Mortality in Down's syndrome in relation to congenital malformations.

C Frid1, P Drott, B Lundell, F Rasmussen, G Annerén.   

Abstract

Down's syndrome (DS) is the most common form of intellectual disability. The syndrome is characterized by congenital malformations, especially of the heart and gastrointestinal tract, which can result in high mortality rates in the affected population. Many improvements have been made in the medical treatment of this syndrome during the past few decades and the survival of individuals with DS has increased in the industrial world. The aim of the present study was to investigate mortality in relation to congenital malformations. Medical records from all liveborn children with DS delivered between 1973 and 1980 in northern Sweden were studied, and malformations and causes of death were recorded. Out of the 219 children included in the study, a congenital heart defect was reported in 47.5% of subjects, 42.1% of whom had complete atrioventricular septal defect. Gastrointestinal tract malformations were present in 7.3% of subjects, and was frequently associated with a cardiac malformation and a very high mortality rate. Other major and minor congenital anomalies were present in 5.5% and 5.5% of subjects, respectively. In the 14.5-year follow-up of 213 children, the rate of survival was 75.6%. Mortality rates within one and 10 years after birth were 14.6% and 23.5%, respectively. Mortality within 10 years differed significantly between children with (44.1%) and without (4.5%) a congenital heart defect. A very high mortality rate was observed among children with a congenital heart defect, especially when it was combined with a gastrointestinal malformation.

Entities:  

Mesh:

Year:  1999        PMID: 10392609     DOI: 10.1046/j.1365-2788.1999.00198.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  21 in total

1.  Marfan syndrome masked by Down syndrome?

Authors:  J C Vis; K van Engelen; J Timmermans; B C Hamel; B J M Mulder
Journal:  Neth Heart J       Date:  2009-09       Impact factor: 2.380

2.  Growth charts for Down's syndrome from birth to 18 years of age.

Authors:  A Myrelid; J Gustafsson; B Ollars; G Annerén
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

Review 3.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

4.  Survival analysis of Down syndrome cohort in a tertiary health care center in India.

Authors:  Risha Nahar; Udhaya Kotecha; Ratna Dua Puri; Ravindra Mohan Pandey; Ishwar Chander Verma
Journal:  Indian J Pediatr       Date:  2012-07-26       Impact factor: 1.967

5.  Co-morbidities leading to mortality or hospitalization in children with Down syndrome and its effect on the quality of life of their parents.

Authors:  Seema Kapoor; Swati Bhayana; Ankur Singh; Jugal Kishore
Journal:  Indian J Pediatr       Date:  2014-05-14       Impact factor: 1.967

Review 6.  Cytogenomic Aberrations in Congenital Cardiovascular Malformations.

Authors:  Mahshid Azamian; Seema R Lalani
Journal:  Mol Syndromol       Date:  2016-04-26

7.  Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects.

Authors:  S B Freeman; C P Torfs; P A Romitti; M H Royle; C Druschel; C A Hobbs; S L Sherman
Journal:  Clin Genet       Date:  2008-11-17       Impact factor: 4.438

8.  Hirschsprung's disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

Review 9.  Organising healthcare services for persons with an intellectual disability.

Authors:  Robert Balogh; Carly A McMorris; Yona Lunsky; Helene Ouellette-Kuntz; Laurie Bourne; Angela Colantonio; Daniela C Gonçalves-Bradley
Journal:  Cochrane Database Syst Rev       Date:  2016-04-11

Review 10.  MicroRNAs in congenital heart disease.

Authors:  Tanya Smith; Cha Rajakaruna; Massimo Caputo; Costanza Emanueli
Journal:  Ann Transl Med       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.